Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

Citations Report

Citations Report - Journal of Leukemia [386 Articles]

The articles published in Journal of Leukemia have been cited 386 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Journal of Leukemia.

Manasa P. Epigenetics–role as biomarker in cancer diagnosis. Adv. Oncol. Res. Treat. 2016;2:r001.

Babatunde AS, Olawumi HO, Durotoye IA, Shittu AO, Sanni EO, Oyeleke SA. Pattern of neurological complications of chronic myeloid leukaemia in Ilorin, Nigeria: A ten year review. Archives of Clinical Research (ACR).:10.

Sankar SP, Mathew A, Jayakumar T, Chand S, Mathew C. Asian Journal of Pharmaceutical and Health Sciences.

Becerra-Pedraza LC, Jiménez-Martínez LE, Peña-Morfin I, Nava-Esquivel R, Villegas-Martínez JA. Priapism as the initial sign in hematologic disease: Case report and literature review. International journal of surgery case reports. 2018 Jan 1;43:13-7.

Ahmed TM, Ahmed AA. Immunohistochemical Expression of CD26 in Bone Marrow Biopsies of Chronic Lymphocytic Leukemia Patients. Indian Journal of Public Health Research & Development. 2019 Feb 1;10(2).

Vosoughi T, Bagheri M, Hosseinzadeh M, Ehsanpour A, Davari N, Saki N. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis. Journal of cellular physiology. 2019 May 2.

Abdelrahman AH, Ibrahim MH, Hamza MT, Eid OM, Hassan EM, Kamel SA, Eid MM, Shahin RY, Sallam MT. Relevance of CD49d and CD38 expressions as predictors of disease progression in chronic lymphocytic leukemia. The Egyptian Journal of Haematology. 2018 Apr 1;43(2):88.

Zaki EM, El-Gammal SA, Sayed NG, Sediek MF, Mohamed AA. The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia. Journal of Advances in Medicine and Medical Research. 2019 Mar 20:1-9.

Enz N, Vliegen G, De Meester I, Jungraithmayr W. CD26/DPP4-a potential biomarker and target for cancer therapy. Pharmacology & therapeutics. 2019 Jun 1;198:135-59.

Vaisitti T, Arruga F, Deaglio S. Targeting the adenosinergic axis in chronic lymphocytic leukemia: a way to disrupt the tumor niche?. International journal of molecular sciences. 2018 Apr;19(4):1167.

Hendy OM, El Shafie MA, Allam MM, Motalib TA, Khalaf FA, Gohar SF. The diagnostic and prognostic value of CD38 and CD49d expressions in chronic lymphocytic leukemia. The Egyptian Journal of Haematology. 2016 Apr 1;41(2):70.

Ye C, Tian X, Yue G, Yan L, Guan X, Wang S, Hao C. Suppression of CD26 inhibits growth and metastasis of pancreatic cancer. Tumor Biology. 2016 Dec 1;37(12):15677-86.

Suryani DP, Oktarlina RZ. Eritroderma et causa Alergi Obat. Jurnal Majority. 2017 Mar 1;6(2):100-4.

Mota C. Detection of Intracellular Cytokeratin 20 in CD14dim Monocytes: A Potential Tool for the Screening of Colorectal Adenocarcinoma in Peripheral Blood (Doctoral dissertation).

Özcan A. Akut myeloid lösemi hastalar─▒nda kopya say─▒s─▒ de─či┼čikliklerinin dizin temelli kar┼č─▒la┼čt─▒rmal─▒ genomik hibridizasyon yöntemi ile de─čerlendirilmesi.

Shukla P. Umbilical cord preservation-A Review. Biochem Mol Biol Lett. 2017;3(1):109.

Shukla P. Umbilical cord preservation-A Review. Biochem Mol Biol Lett. 2017;3(1):109.

Kamini J. Why Imatinib is by Far the Best Drug to Treat Chronic Myeloid Leukemia. Biochem Mol Biol Lett. 2017;3(2):112.

Shukla P. Umbilical cord preservation-A Review. Biochem Mol Biol Lett. 2017;3(1):109.

Roop P, Angmo D, Kamble N, Tomar AS. Uncontrolled neovascular glaucoma–an alarming manifestation of chronic myeloid leukemia on imatinib therapy–a case report and review of literature. Indian journal of ophthalmology. 2019 Feb;67(2):285.

Relevant Topics